Satomi Watanabe

Kishiwada, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design).

Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design).

Journal: Future oncology (London, England)

Published: April 15, 2026

Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B).

Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B).

Journal: Breast cancer research and treatment

Published: March 30, 2026

Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors.

Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors.

Journal: Cancer research communications

Published: August 24, 2025

Clinical and molecular landscape of metastatic extramammary Paget's disease.

Clinical and molecular landscape of metastatic extramammary Paget's disease.

Journal: The oncologist

Published: May 06, 2025

Pharmacokinetics, efficacy and safety of palbociclib and fulvestrant in a patient with hormone receptor-positive, human epidermal growth factor receptor 2 negative metastatic breast cancer with end-stage renal disease undergoing hemodialysis: A case report.

Pharmacokinetics, efficacy and safety of palbociclib and fulvestrant in a patient with hormone receptor-positive, human epidermal growth factor receptor 2 negative metastatic breast cancer with end-stage renal disease undergoing hemodialysis: A case report.

Journal: Investigational new drugs

Published: April 03, 2025

Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case report.

Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case report.

Journal: Thoracic cancer

Published: November 01, 2022

Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study.

Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study.

Journal: Investigational new drugs

Published: July 09, 2022

Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen.

Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen.

Journal: Investigational new drugs

Published: June 25, 2021

Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplication.

Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplication.

Journal: Thoracic cancer

Published: May 21, 2021

Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion-Positive Breast Cancer.

Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion-Positive Breast Cancer.

Journal: JCO precision oncology

Published: July 18, 2020

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Journal: The oncologist

Published: June 24, 2020

Psychosocial effects of appearance changes due to cancer treatment and needs for information and supportive care in Japanese cancer patients.

Psychosocial effects of appearance changes due to cancer treatment and needs for information and supportive care in Japanese cancer patients.

Journal: Asia-Pacific journal of clinical oncology

Published: July 25, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026